Rheumatic Heart Disease Management Market Led by India as Novartis and Pfizer Drive Growth

According to the latest market analysis by Future Market Insights, the global rheumatic heart disease management market is witnessing steady growth supported by increasing prevalence of rheumatic heart disease in developing regions, expanding access to cardiac healthcare services, growing adoption of minimally invasive surgical procedures, and continued advancements in valve replacement and repair technologies.

Market analysis indicates the rheumatic heart disease management market was valued at USD 1.43 billion in 2025 and is projected to reach approximately USD 1.49 billion by 2026-end before expanding to USD 2.2 billion by 2036, reflecting a CAGR of 4.0% during the 2026-2036 forecast period.

The market is projected to create an incremental opportunity of approximately USD 0.71 billion between 2026 and 2036, supported by improving cardiac care infrastructure, government-led screening initiatives, growing awareness regarding rheumatic fever complications, and increasing availability of advanced treatment technologies.

Quick Stats: Rheumatic Heart Disease Management Market

• Market Value (2025): USD 1.43 Billion
• Estimated Market Size (2026): USD 1.49 Billion
• Forecast Market Value (2036): USD 2.2 Billion
• CAGR (2026-2036): 4.0%
• Incremental Opportunity (2026-2036): USD 0.71 Billion
• Leading Product Category Segment (2026): Valve - 61.4% Share
• Leading Application Segment (2026): Hospitals - 68.9% Share
• Leading Technology Segment (2026): Minimally Invasive Surgery - 42.8% Share
• Fastest Growing Markets: EU (4.1%) and South Korea (4.1%)

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16349

Rising Burden of Rheumatic Heart Disease Continues to Support Market
Expansion

The increasing prevalence of rheumatic fever and its long-term cardiac complications remains a major factor driving demand across the rheumatic heart disease management market.

Minimally Invasive Cardiac Procedures Create New Growth Opportunities
The growing adoption of minimally invasive surgical approaches is transforming the treatment landscape by improving procedural outcomes while reducing recovery times and healthcare costs.

Modern treatment solutions help:

• Reduce procedural complications
• Improve patient recovery times
• Lower hospitalization duration
• Enhance treatment accessibility
• Improve long-term clinical outcomes

Valve Products Maintain Leading Market Position

Valve products are expected to remain the leading product category segment in 2026, accounting for approximately 61.4% of the global market share.

Demand remains strong due to:

• Central role of valve replacement and repair procedures
• Growing adoption of prosthetic valve technologies
• Rising prevalence of valvular heart complications
• Increasing availability of transcatheter interventions

Hospitals Lead Application Segment Adoption

Hospitals are projected to account for approximately 68.9% of the application segment in 2026, supported by the need for specialized cardiac surgery teams, intensive care capabilities, advanced imaging technologies, and comprehensive post-operative care.

Growing investment in cardiac centers of excellence and tertiary care hospitals continues supporting segment growth globally.

Regional Outlook: EU and South Korea Lead Global Market Expansion

European Union
The European Union continues demonstrating strong market growth supported by advanced cardiac care systems, favorable reimbursement frameworks, increasing adoption of minimally invasive interventions, and widespread availability of innovative valve technologies.
The region is projected to expand at a CAGR of 4.1% through 2036.

South Korea
South Korea continues witnessing healthy market growth supported by high healthcare spending, advanced cardiovascular treatment infrastructure, and rapid adoption of next-generation interventional technologies.
The country is projected to expand at a CAGR of 4.1% through 2036.

United Kingdom
The United Kingdom continues maintaining stable market growth supported by NHS cardiac care programs, ongoing investment in surgical innovation, and structured patient management pathways.
The country is projected to expand at a CAGR of 4.0% through 2036.

Japan
Japan continues experiencing steady market expansion supported by advanced healthcare infrastructure, aging population demographics, and increasing utilization of sophisticated cardiac surgical procedures.
The country is projected to expand at a CAGR of 4.0% through 2036.

United States
The United States continues generating significant market demand supported by advanced cardiac care capabilities, favorable reimbursement structures, and growing adoption of minimally invasive valve replacement procedures.
The country is projected to expand at a CAGR of 3.9% through 2036.

Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-16349

Competitive Landscape Focuses on Cardiac Innovation and Advanced Valve
Technologies

The rheumatic heart disease management market remains highly competitive, with leading companies focusing on expanding cardiac device portfolios, improving structural heart technologies, strengthening hospital partnerships, and advancing minimally invasive treatment solutions.

Key Industry Participants Include:

• Abbott Laboratories
• Novartis
• Bayer
• Roche
• BIOTRONIK
• Bristol-Myers Squibb
• Cardinal Health
• Cook Medical

Outlook Through 2036

The rheumatic heart disease management market is expected to maintain steady long-term growth as healthcare providers increasingly prioritize early diagnosis, advanced intervention techniques, and long-term patient monitoring strategies.

Future market growth is expected to be supported by:
• Increasing prevalence of rheumatic heart disease globally
• Expansion of cardiac screening and prevention programs
• Growing adoption of minimally invasive valve procedures
• Rising investment in healthcare infrastructure across developing economies
• Advancements in transcatheter and prosthetic valve technologies
• Increasing utilization of telemedicine and remote cardiac monitoring solutions
• Strengthening global access to specialized cardiovascular care

Explore In-Depth Healthcare Market Insights: https://www.futuremarketinsights.com/industry-analysis/healthcare

Explore Industry Insights: https://www.futuremarketinsights.com/industry-analysis

Purchase Full Report for Detailed Insights: https://www.futuremarketinsights.com/reports/rheumatic-heart-disease-management-market

Why FMI: https://www.futuremarketinsights.com/why-fmi

Explore More Related Studies Published by FMI Research:

Bariatric Surgery Device Market:
https://www.futuremarketinsights.com/reports/bariatric-surgery-devices-market

Wearable Medical Device Market: https://www.futuremarketinsights.com/reports/wearable-medical-devices-market

Veterinary CRISPR-Based Detection Kits Market: https://www.futuremarketinsights.com/reports/veterinary-crispr-based-detection-kits-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.